Skip to main content

The LLS Blog

Read about survivors, research, fundraising and advocacy.

LLS’s Therapy Acceleration Program Accelerates Progress for Patients

In 2007, when I served as The Leukemia & Lymphoma Society’s Chief Scientific Officer, I conceived and launched the LLS venture philanthropy initiative, the Therapy Acceleration Program (TAP). Our goal was to expand beyond traditional research grants and to bring much-needed therapies into clinical studies faster. And I’m pleased to share we’ve made a real impact.

LLS & BURLINGTON STORES SURPRISE PEDIATRIC CANCER SURVIVORS WITH ONE-OF-A-KIND OUTDOOR “PATIENT PARADES” AT SELECT STORE LOCATIONS NATIONWIDE

As part of Burlington’s annual in-store fundraising campaign, they’re hosting celebratory drive-by ‘parades’ for children battling cancer...

Stronger Together: Navigating Cancer as Newlyweds

As we round out our first year of marriage and our first year of battling cancer, I recently asked my husband Brad how he would describe this past year. “Disrupted.” Before cancer, we had plans: big, extravagant, travel-the-world kind of plans. After two years of a long-distance relationship, we were finally going to live in the same city. We were going to get settled in our brand-new home. We were going to make new Florida friends. We were excited about the opportunities we had in our careers. We were going to capitalize on the “newlywed phase” to the fullest extent! Then, we learned that cancer doesn’t care if you’re newly married with plans in place; it can rock your world in an instant.

Meet the Researcher: Maria Figueroa, MD

Dr. Maria “Ken” Figueroa, Associate Professor at Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, is focused on an exciting area of research called epigenetics. Epigenetics refers to chemical modifications that regulate (switch on and off) gene activity. With support from LLS, Dr. Figueroa is studying how the epigenetic changes that occur as people age may contribute to acute myeloid leukemia (AML) and other blood cancers.

Older Posts